ArticleThrombosis journal2022

Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data.

Lisette Warkentin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.